1.08212
Parteck® PLX 188 (Poloxamer 188)
(stabilized with 70ppm BHT), EMPROVE® ESSENTIAL, Ph. Eur., ChP, NF
동의어(들):
Poloxamer 188
조직 및 계약 가격을 보려면 로그인를 클릭합니다.
크기 선택
보기 변경
제품정보 (DICE 배송 시 비용 별도)
biological source
synthetic
Quality Level
agency
ChP, NF, Ph. Eur.
product line
EMPROVE® ESSENTIAL
bp
>150 °C
mp
55 °C
bulk density
1050 kg/m3
storage temp.
2-25°C
SMILES string
O2C(C2)C.O1CC1
InChI
1S/C3H6O.C2H4O/c1-3-2-4-3;1-2-3-1/h3H,2H2,1H3;1-2H2
InChI key
RVGRUAULSDPKGF-UHFFFAOYSA-N
General description
With formulation challenges in mind, we have used particle engineering technologies to develop functional excipients specifically for solid oral dosage forms. The products in our Parteck® portfolio feature unique particle properties tailored for excellent performance in tableting processes, for specific drug delivery technologies, or for solubility enhancement.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.
Application
Parteck® PLX 188 excipient combines adequate lubrication at tolerable concentrations with the added benefit of dissolution enhancement. It features consistent performance, improved dissolution rate and reliable lubrication – all at the same time. As a result, Parteck® PLX 188 excipient can therefore provide a simple solution to low bioavailability of DCS 2a compounds.
Features and Benefits
- Hydrophilic, water-soluble tablet lubrication
- Improved dissolution rates for poorly soluble DCS class IIa molecules
- Specified particle size distribution optimized for solid application performance
- Regulatory support through compliance with Ph. Eur. and USP-NF, going beyond current requirements with specitied formaldehyde content
Legal Information
Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
PARTECK is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany
저장 등급
11 - Combustible Solids
wgk
WGK 1
flash_point_f
>302.0 °F
flash_point_c
> 150 °C
Emprove® 프로그램을 사용하여 GMP 준수 유지
Emprove® Dossiers로 자격을 가속화하고, 규정 준수를 유지하며, 시간을 절약하세요.
Dossiers 다운로드
주: EmproveSuite.com으로 이동하게 됩니다. 귀하의 사용자 이름과 비밀번호는 시그마알드리치닷컴과는 별개이며 다를 수 있습니다.
무료로 등록하고 몇 분 안에 Emprove® Dossiers에 액세스하세요. 구독 플랜을 업그레이드하여 Emprove® Suite에서 고급 및 맞춤형 콘텐츠를 잠금 해제하세요.
원하는 정보를 찾지 못하셨나요? Emprove® 프로그램 도움말 페이지 방문하기.
문서
Our overview of API solubility and dissolution enhancement methods can help you decide between the many options to take during formulation.
국제 무역 품목 번호
| SKU | GTIN |
|---|---|
| 1.08212.9025 | 04061841048671 |
| 1.08212.0500 | 04061841048657 |
| 1.08212.0001 | 04061841048640 |